Kristen L. Alexander

Insider Reports History

Location
The Woodlands, TX
Signature
/s/ Kristen L. Alexander
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kristen L. Alexander:

Company Role Class Num Shares Value Price $ Report Date Ownership
LEXICON PHARMACEUTICALS, INC. VP, Finance and Accounting Common Stock 76,368 $51,167 $0.6700 28 Feb 2025 Direct
LEXICON PHARMACEUTICALS, INC. VP, Finance and Accounting Restricted Stock Units 39,773 $26,648 $0.6700 28 Feb 2025 Direct
LEXICON PHARMACEUTICALS, INC. VP, Finance and Accounting Stock Option (Right to Buy) 185,540 13 Feb 2025 Direct

Insider Reports Filed by Kristen L. Alexander

Symbol Company Period Transactions Value $ Form Type Role Filing Time
LXRX LEXICON PHARMACEUTICALS, INC. 28 Feb 2025 7 -$11,968 4 VP, Finance and Accounting 03 Mar 2025, 16:33
LXRX LEXICON PHARMACEUTICALS, INC. 13 Feb 2025 2 $0 4 VP, Finance and Accounting 18 Feb 2025, 16:22
LXRX LEXICON PHARMACEUTICALS, INC. 28 Feb 2024 7 -$30,898 4 VP, Finance and Accounting 29 Feb 2024, 16:33
LXRX LEXICON PHARMACEUTICALS, INC. 08 Feb 2024 2 $0 4 VP, Finance and Accounting 12 Feb 2024, 16:19
LXRX LEXICON PHARMACEUTICALS, INC. 28 Feb 2023 7 -$11,566 4 VP, Finance and Accounting 01 Mar 2023, 15:56
LXRX LEXICON PHARMACEUTICALS, INC. 09 Feb 2023 2 $0 4 VP, Finance and Accounting 13 Feb 2023, 16:06
LXRX LEXICON PHARMACEUTICALS, INC. 28 Feb 2022 7 -$9,510 4 VP, Finance and Accounting 28 Feb 2022, 18:18
LXRX LEXICON PHARMACEUTICALS, INC. 10 Feb 2022 2 $0 4 VP, Finance and Accounting 14 Feb 2022, 15:02
LXRX LEXICON PHARMACEUTICALS, INC. 25 Sep 2021 0 $0 3 VP, Finance and Accounting 27 Sep 2021, 16:06